Tag: Health Care

Displaying 1 - 20 of 1368 results.

Pages

On January 14, 2020, the Federal Trade Commission (FTC) ordered six insurance companies to provide information that will allow the agency to study the effects of consummated physician group and healthcare facility mergers that occurred from 2015 through 2020.
The Federal Trade Commission filed an administrative complaint and authorized a federal court lawsuit to block Illumina’s $7.1 billion proposed acquisition of Grail—a maker of a non-invasive, early detection liquid biopsy test that can screen for multiple types of cancer in...
The Federal Trade Commission has filed an administrative complaint and authorized a federal court lawsuit to block Illumina’s $7.1 billion proposed acquisition of Grail—a maker of a non-invasive, early detection liquid biopsy test that can screen for multiple types of cancer in asymptomatic...
Acting Federal Trade Commission Chairwoman Rebecca Kelly Slaughter released the Commission’s 2020 Annual Highlights today, emphasizing the agency’s ongoing efforts to protect consumers and promote competition.
Note: The FTC will host a conference call TODAY for media at 11:30 ET with Acting Chairwoman Rebecca Kelly Slaughter. The call-in number is 844-291-6360 and the access code is 4928954. Call-in lines, which are for media only, will open 15 minutes prior to the start of the call.
Given the announcement from Atrium Health Navicent, Inc. and Houston Healthcare System, Inc. that they are abandoning their proposed merger, the Federal Trade Commission has closed its investigation into the proposed transaction.
The Federal Trade Commission finalized a settlement with a Nevada-based company that provides travel emergency services over allegations it failed to take reasonable steps to secure sensitive consumer information such as health records.
The FTC is suing Endo Pharmaceuticals, Inc., Endo International plc, Impax Laboratories, LLC, and Impax’s owner, Amneal Pharmaceuticals, Inc., alleging that a 2017 agreement between Endo and Impax violated the antitrust laws by eliminating competition in the market for oxymorphone ER...
The FTC is suing Endo Pharmaceuticals Inc., Endo International plc, Impax Laboratories, LLC, and Impax’s owner, Amneal Pharmaceuticals, Inc., alleging that a 2017 agreement between Endo and Impax violated the antitrust laws by eliminating competition in the market for oxymorphone ER. The FTC sued...
The Federal Trade Commission staff has submitted a comment to the Department of Veterans Affairs (VA) in response to its request for comment on its Interim Final Rule titled Authority of VA Professionals to Practice Health Care.
The Federal Trade Commission has issued orders to six health insurance companies to provide information that will allow the agency to study the effects of physician group and healthcare facility consolidation that occurred from 2015 through 2020.

Pages